Deerfield Special Situations Fund, L.P., 10% Owner at Vanda Pharmaceuticals Inc. (VNDA), bought 775,382 shares at $8.21 ($6.4M) on 2015-12-09, disclosed to the SEC on 2015-12-11.
Open-market purchase of $6.4M VNDA by 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $8.21 | 213,358 | $1.8M | 27.4% |
| 2 | $8.21 | 229,833 | $1.9M | 29.5% |
| 3 | $8.21 | 292,515 | $2.4M | 37.5% |
| 4 | $9.00 | 11,506 | $104K | 1.6% |
| 5 | $9.00 | 12,395 | $112K | 1.7% |
| 6 | $9.00 | 15,775 |
| $142K |
| 2.2% |
| Total | $8.25 avg | 775,382 | $6.4M | 100% |
| Filing → |
| VNDA | BUY | 2015-12-18 | $3.7M | — | Filing → |
| ALIM | BUY | 2015-12-08 | $494K | — | Filing → |
| ALIM | BUY | 2015-10-21 | $580K | — | Filing → |